These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Geddes JR; Burgess S; Hawton K; Jamison K; Goodwin GM Am J Psychiatry; 2004 Feb; 161(2):217-22. PubMed ID: 14754766 [TBL] [Abstract][Full Text] [Related]
10. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. Ketter TA; Houston JP; Adams DH; Risser RC; Meyers AL; Williamson DJ; Tohen M J Clin Psychiatry; 2006 Jan; 67(1):95-101. PubMed ID: 16426094 [TBL] [Abstract][Full Text] [Related]
11. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488 [TBL] [Abstract][Full Text] [Related]
12. Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications. Bowden CL; Karayal ON; Schwartz JH; Gundapaneni BK; O'Gorman C J Affect Disord; 2013 Jan; 144(1-2):171-5. PubMed ID: 22999893 [TBL] [Abstract][Full Text] [Related]
13. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Smith LA; Cornelius V; Warnock A; Bell A; Young AH Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study. Peselow ED; Clevenger S; IsHak WW Int Clin Psychopharmacol; 2016 Jul; 31(4):218-23. PubMed ID: 26523730 [TBL] [Abstract][Full Text] [Related]
16. Risperidone adjunctive therapy duration in the maintenance treatment of bipolar I disorder: A post hoc analysis. Valdes M; Bertolin S; Qian H; Wong H; Lam RW; Yatham LN J Affect Disord; 2019 Mar; 246():861-866. PubMed ID: 30795492 [TBL] [Abstract][Full Text] [Related]
17. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. Altshuler L; Kiriakos L; Calcagno J; Goodman R; Gitlin M; Frye M; Mintz J J Clin Psychiatry; 2001 Aug; 62(8):612-6. PubMed ID: 11561933 [TBL] [Abstract][Full Text] [Related]
18. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample. Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464 [TBL] [Abstract][Full Text] [Related]
19. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder. Yatham LN J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077 [TBL] [Abstract][Full Text] [Related]
20. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]